ADVENZYMESAdvanced Enzyme Technologies Ltd.
Advanced Enzyme Technologies buys back no shares on 30 Oct 2026
- Corporate action
- Enzymes and specialty ingredients
Reviewed byRachit TripathiBlacklitt Research
Advanced Enzyme Technologies (NSE: ADVENZYMES) bought back no equity shares on 30 Oct 2026 under its buyback, leaving the total at 24,10,906 shares, it said in a filing on 30 Oct 2026. The broker for the day was Emkay Global Financial Services Limited.
Key highlights
- Shares bought back on 30 Oct 2026: Nil
- Total shares bought back as on 30 Oct 2026: 24,10,906
- Cumulative as on 29 Oct 2026: 24,10,906
- Shares closed out to date: Nil
- Face value per share: ₹2
The buyback in numbers
| Item | Detail |
|---|---|
| Broker | Emkay Global Financial Services Limited |
| Shares bought back on 30 Oct 2026 | Nil |
| Cumulative as on 29 Oct 2026 | 24,10,906 shares |
| Total as on 30 Oct 2026 | 24,10,906 shares |
| Shares closed out to date | Nil |
| Face value per share | ₹2 |
| Report date | 30 Oct 2026 |
No shares bought on 30 Oct 2026
On 30 Oct 2026 the company bought back no equity shares through Emkay Global Financial Services Limited, the only broker named in the report.
With no shares closed out, the total of 24,10,906 shares is the same as the cumulative figure reported for the previous day.
How the running total has moved
The report gives only the running count of shares and no rupee value, so the amount spent on the buyback to date cannot be worked out from this filing.
What the daily report means for Advanced Enzyme Technologies' shareholders
The report records no purchases on 30 Oct 2026, so the cumulative count of bought-back shares is unchanged for the day. The filing does not say the buyback price, the total rupee size, the buyback period or closing date, or the reason for the buyback. The company says the details will also be posted on its website and on the BSE and NSE websites.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
